On October 24, 2012 the FDA approved Perampanel as an adjunct treatment for refractory partial-onset seizures in patients with epilepsy aged 12 years and older. A step forward for us all. Here’s why…
Most Recent Posts
Top posts
About the author
I've been a professional copywriter for over 35 years. I also had epilepsy for decades. My mission is advocacy; to increase education, awareness and funding for epilepsy research. Together, we can make a huge difference. If not changing the world, at least helping each other, with wisdom, compassion and sharing.
